Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

Item

http://www.wikidata.org/entity/Q34407296

Q34407296

about

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects Heparin in interventional radiology: a therapy in evolution Novel approaches for the prevention of restenosis.Low molecular weight heparins for arterial thrombosis.Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature.Heparin dose during percutaneous coronary intervention: how low dare we go?Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.Low-molecular-weight heparins in the cardiac catheterization laboratory Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.Interaction between the LMWH reviparin and aspirin in healthy volunteers.Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis.Peri-procedural myocardial injury: 2005 update.Adjunctive pharmacotherapy for coronary interventions-time to read the writing on the wall.Pharmacological antithrombotic adjuncts to percutaneous coronary intervention.Periprocedural routines of coronary angioplasty--extreme diversity with unrevealed consequences.Effects of heparin on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells.Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.Low-molecular-weight heparin in arterial reconstructive surgery: a double-blind, randomized dose-finding trial.Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study.

P2860

Q24793199-EC85F20F-6913-42DE-A819-C636F014D472 Q26853150-4312098E-7804-4FFE-BCA3-65C6E334B8DD Q28189075-B86639E1-4069-4B03-B87C-54673ED56A4D Q33394179-C9C16412-0C0E-42AF-AB3F-0B7F92BB9042 Q34075160-D98AF804-60B8-4AF4-8A06-4456FDAE8A56 Q34158943-6EF3F652-292B-4C27-A5C1-2C0E7DA4A4A8 Q34445660-C63F8C05-F29C-4216-8927-B317D27D55CA Q34733613-43CF9C30-8336-4F83-BF8B-1C0F428F89FD Q34858594-2078A6DA-530F-4F6B-A4E3-5B65F7A6ED04 Q35582491-B1AA7556-7AF0-454C-ABBE-6A0EA1C66EB7 Q35733959-D731480E-2062-4AB5-8AFA-29E4A19D072B Q35944733-7AA0AB86-2EE4-4593-BCA1-B823FCE5892C Q36055143-EF7E6FCB-2590-431F-B32D-8B643BA8D4EC Q36131116-2FA85692-798B-4F31-AA94-A662E0CB8DA2 Q36263844-2C2C24F7-500B-446B-B006-CA335F2E2E03 Q36680683-7AFFB2A5-3A61-4BB1-A3DB-C4142CB0BFC8 Q36787291-C70485C3-6EDD-4BED-ADFD-B2A90211EA42 Q39220658-DDB0E90C-D31D-43D7-B6A5-F8DD8BC79814 Q41879658-0880540A-B9B3-4AF2-AEF1-42B83833D284 Q43013493-48266F0F-189B-4FDC-90EA-AD5D3DB707BC Q47173857-D3AFA282-A595-4EFB-9601-7011BFECEC49 Q47274464-3891E3C0-8576-4FF8-BB96-1725490539AE

P2860

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

Item

http://www.wikidata.org/entity/Q34407296

description

1996 nî lūn-bûn

@nan

1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu